Search results
Showing 1 to 5 of 5 results for ta245
Evidence-based recommendations on apixaban (Eliquis) for preventing venous thromboembolism after total hip or knee replacement in adults.
Recommendation ID TA245/1 Question More trials of apixaban compared with other low molecular weight heparin (LMWHs) in total hip and knee
This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.
QS33 for various DMARDs prescribing in primary care NG5, CG180, KTT16, TA245, TA256, TA275, TA287, TA335, TA355, TA354, TA157, TA249,...
TA245/1 | More trials of apixaban compared with other low molecular weight heparin